Adjustments for Non-Cash Items [USD, Millions]

Stock-Based Compensation [USD, Millions]

Changes in Working Capital [USD, Millions]

Capital Expenditures (CapEx) [USD, Millions]

Proceeds from / Repayments of Debt [USD, Millions]

Share Repurchases [USD, Millions]

Dividend Payments [USD, Millions]

Net Change in Cash [USD, Millions]

0a037cf7b7899fb727ee16232d12f7315e3d90469bb2c59458d1c48f5c7847eb

f09d13f835a7ca0abda8c7eee986278071491866f93e6e46b23c9731acccef75

Americas

- United States

- Other Americas

Europe and Africa

- United Kingdom

- Other Europe and Africa

Asia-Pacific

- Japan

- Other Asia-Pacific

Total Revenue

760992bc442ea9f51149ce10f11da5122e4a9aee53e3645627f28b226c1755e6

f590163adddba6ea6e7340d5bdd8c7323296f29999e0c97c80f68202b1c08ecb

Number of employees worldwide (employees)

Number of countries in which the company operates (countries)

Contracted backlog for Research & Development Solutions (USD billions)

Value of backlog expected to convert to revenues in the next twelve months for Research & Development Solutions (USD billions)

934b4d7fd7f2d7ae0c7c3ad80dde554fdd3b8cfff25cfe9d9263e70c82b83c88

Net Income (USD, millions)

Depreciation and Amortization (USD, millions)

Amortization of Debt Issuance Costs and Discount (USD, millions)

Stock-Based Compensation (USD, millions)

Gain on Disposals of Property and Equipment, Net (USD, millions)

(Earnings) Losses from Unconsolidated Affiliates (USD, millions)

(Gain) Loss on Investments, Net (USD, millions)

Benefit from Deferred Income Taxes (USD, millions)

Change in Accounts Receivable, Unbilled Services and Unearned Income (USD, millions)

Change in Other Operating Assets and Liabilities (USD, millions)

Net Cash Provided by Operating Activities (USD, millions)

Acquisition of Property, Equipment and Software (USD, millions)

Acquisition of Businesses, Net of Cash Acquired (USD, millions)

Purchases of Marketable Securities, Net (USD, millions)

Investments in Unconsolidated Affiliates, Net of Payments Received (USD, millions)

Investments in Debt and Equity Securities (USD, millions)

Proceeds from Sale of Property, Equipment and Software (USD, millions)

Other Investing Activities (USD, millions)

Net Cash Used in Investing Activities (USD, millions)

Proceeds from Issuance of Debt (USD, millions)

Payment of Debt Issuance Costs (USD, millions)

Repayment of Debt and Principal Payments on Finance Leases (USD, millions)

Proceeds from Revolving Credit Facility (USD, millions)

Repayment of Revolving Credit Facility (USD, millions)

Payments Related to Employee Stock Incentive Plans, Net (USD, millions)

Repurchase of Common Stock (USD, millions)

Contingent Consideration and Deferred Purchase Price Payments (USD, millions)

Net Cash Used in Financing Activities (USD, millions)

Net Cash (Used in) Provided by Financing Activities (USD, millions)

Effect of Foreign Currency Exchange Rate Changes on Cash (USD, millions)

Increase (Decrease) in Cash and Cash Equivalents (USD, millions)

Accounts Receivable and Unbilled Services (USD, millions)

Prepaid Expenses and Other Assets (USD, millions)

Accounts Payable and Accrued Expenses (USD, millions)

Unearned Income (USD, millions)

Income Taxes Payable and Other Liabilities (USD, millions)

Cash and Cash Equivalents at Beginning of Period (USD, millions)

Cash and Cash Equivalents at End of Period (USD, millions)

97332b1a7cc865161bc740e94adf415679c685e851b924bfa2b92104fece0444

Cash and cash equivalents (USD, millions)

Trade accounts receivable and unbilled services, net (USD, millions)

Prepaid expenses (USD, millions)

Income taxes receivable (USD, millions)

Investments in debt, equity and other securities (Current) (USD, millions)

Other current assets and receivables (USD, millions)

Total current assets (USD, millions)

Property and equipment, net (USD, millions)

Operating lease right-of-use assets (USD, millions)

Investments in debt, equity and other securities (Non-Current) (USD, millions)

Investments in unconsolidated affiliates (USD, millions)

Goodwill (USD, millions)

Other identifiable intangibles, net (USD, millions)

Deferred income taxes (Assets) (USD, millions)

Deposits and other assets, net (USD, millions)

Total assets (USD, millions)

Accounts payable and accrued expenses (USD, millions)

Unearned income (USD, millions)

Income taxes payable (USD, millions)

Current portion of long-term debt (USD, millions)

Other current liabilities (USD, millions)

Total current liabilities (USD, millions)

Long-term debt, less current portion (USD, millions)

Deferred income taxes (Liabilities) (USD, millions)

Operating lease liabilities (USD, millions)

Other liabilities (USD, millions)

Total liabilities (USD, millions)

Common stock and additional paid-in capital (USD, millions)

Retained earnings (USD, millions)

Treasury stock, at cost (USD, millions)

Accumulated other comprehensive loss (USD, millions)

Total stockholders’ equity (USD, millions)

Total liabilities and stockholders’ equity (USD, millions)

bc3daa62e92d756f89074f0473bff94aab29bae795c736dcff4fe18067506b96

Revenues (USD, millions)

Cost of revenues, exclusive of depreciation and amortization (USD, millions)

Selling, general and administrative expenses (USD, millions)

Depreciation and amortization (USD, millions)

Restructuring costs (USD, millions)

Income from operations (USD, millions)

Interest income (USD, millions)

Interest expense (USD, millions)

Loss on extinguishment of debt (USD, millions)

Other (income) expense, net (USD, millions)

Income before income taxes and equity in earnings (losses) of unconsolidated affiliates (USD, millions)

Income tax expense (USD, millions)

Income before equity in earnings (losses) of unconsolidated affiliates (USD, millions)

Equity in earnings (losses) of unconsolidated affiliates (USD, millions)

Net income (USD, millions)

Basic earnings per share attributable to common stockholders (USD)

Diluted earnings per share attributable to common stockholders (USD)

Weighted average common shares outstanding - Basic (millions)

Weighted average common shares outstanding - Diluted (millions)

354d1526240464b4a9067b01eb130b8d51d8ef76647773de54e62190fc756179

Technology & Analytics Solutions

Research & Development Solutions

Contract Sales & Medical Solutions

Commercial Solutions

Integrated Engagement Services

Product Development

Integrated Healthcare Services

Total Service Revenues

Reimbursed Expenses

1e6af34a3f07874edbe21d9471e14501ef5b945c730d873a750123ce3672100e

IQVIA Holdings Inc (IQV)

Financials